Related Experiment Video
Updated: Nov 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Commentary: Pharmacologic Correlates that Address the Clinicopathobiology of COVID-19
Robert E Brown1, Danyal Tahseen2
1Department of Pathology and Laboratory Medicine UTHealth McGovern Medical School at Houston robert.brown@uth.tmc.edu.
Abstract:
COVID-19 could remain a pandemic until we get a SARS-CoV-2 vaccine to immunize the world population. In the interim, we have the opportunity to consider its clinicopathobiology in the context of the pharmacologic correlates available from the existing medical literature to prevent the COVID-19 infected patient from progressing into a fatal stage. This commentary serves as a forum for that end and suggests relatively non-toxic therapies that could be applied in a combinatorial fashion for consideration by the physicians and their patients with COVID-19 infection.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Factors Affecting Drug Response: Overview
Single Nucleotide Polymorphisms-SNPs
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Pharmacokinetics: Drug–Food and Drug–Viral Interactions

